The trial is continuing as planned and John Hopkins is continuing the treat patients as part of that that trial. The company is restricted from commenting too much on enrollment numbers.
Ann: Imricor Q4 CY24 Quarterly Activities Report and Appendix 4C, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.58 |
Change
-0.040(2.47%) |
Mkt cap ! $506.3M | |||
| Open | High | Low | Value | Volume |
| $1.63 | $1.63 | $1.55 | $523.4K | 327.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1277 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.65 | 6507 | 1 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| IMR (ASX) Chart |